R Squared LTD Biocryst Pharmaceuticals Inc Transaction History
R Squared LTD
- $93.6 Billion
- Q1 2025
A detailed history of R Squared LTD transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, R Squared LTD holds 11,670 shares of BCRX stock, worth $116,233. This represents 0.09% of its overall portfolio holdings.
Number of Shares
11,670
Previous 6,335
84.21%
Holding current value
$116,233
Previous $47.6 Million
83.73%
% of portfolio
0.09%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding BCRX
# of Institutions
293Shares Held
177MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$216 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$199 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$88.9 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$86.7 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$77.8 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.85B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...